<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01050595</url>
  </required_header>
  <id_info>
    <org_study_id>107199</org_study_id>
    <nct_id>NCT01050595</nct_id>
  </id_info>
  <brief_title>Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit</brief_title>
  <acronym>MOVE-IT</acronym>
  <official_title>Methylnaltrexone for the Reversal of Opiate-Induced Constipation in the Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. John Health System, Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. John Health System, Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if there will be a significantly higher incidence
      of a bowel movement with methylnaltrexone vs. placebo within 4 hours +- 45 minutes with
      decreased need for rescue medications in the intensive care unit in patients with
      opioid-induced constipation. Patients will also be managed with an aggressive bowel
      management protocol.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>A significantly higher incidence of a rescue free laxation with methylnaltrexone within 4 hours +- 45 minutes.</measure>
    <time_frame>Nine months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decreased need for rescue medications to have a bowel movement in the treatment arm vs placebo.</measure>
    <time_frame>Nine months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Opioid-induced Constipation</condition>
  <arm_group>
    <arm_group_label>Methylnaltrexone Bromide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylnaltrexone Bromide</intervention_name>
    <description>The experimental group will receive the recommended dose of MNTX (Relistor) is 8 mg for patients weighing 38 kg to less than 62 kg (84 lbs to less than 136 lbs) or 12 mg for patients weighing 62 kg to 114 kg (136 lbs to 251 lbs). Patients whose weight is below 38 kg or greater than 114 kg, will be dosed at 0.15 mg/kg. If creatinine clearance &lt;30 will decrease dose by 50%. This will be given after 72 hours of no bowel movement. Bowel management protocol will be instituted four hours afterward with the methylnaltrexone being given every other day.</description>
    <arm_group_label>Methylnaltrexone Bromide</arm_group_label>
    <other_name>Relistor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo-Normal Saline</intervention_name>
    <description>Control group will be given an equal amount of normal saline in an identically appearing vial every other day until a bowel movement occurs. A bowel management protocol will also be started.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Relistor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older in the ICU

          -  Opioids for analgesia for at least 24 hours.

          -  Opioid-induced constipation with no bowel movement within the last 72 hours.

          -  Women of childbearing potential had negative pregnancy tests.

        Exclusion Criteria:

          -  Contraindication to use of the GI tract

          -  Diarrhea on admission

          -  Bowel surgery within 8 weeks of admission

          -  Ileostomy or colostomy

          -  Not expected to live or stay more than 3 days in the intensive care unit

          -  Constipation that was not primarily caused by opioids (as determined by the
             investigator)

          -  No opioid use in the last 24 hours,

          -  Mechanical gastrointestinal obstruction

          -  An indwelling peritoneal catheter

          -  Clinically active diverticular disease

          -  Fecal impaction

          -  Acute surgical abdomen

          -  History of Crohn's disease or ulcerative colitis

          -  On Palliative care

          -  Less than 18 years old

          -  Bowel movement in last 72 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradford A Whitmer, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Hospital and Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bradford A Whitmer, D.O.</last_name>
    <phone>2482891272</phone>
    <email>whitmer5@msu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Providence Hospital and Medical Center</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynne C Paul, Rn, MSN</last_name>
      <phone>248-849-5805</phone>
      <email>lynne.paul@stjohn.org</email>
    </contact>
    <contact_backup>
      <last_name>Nicole D Bolda</last_name>
      <phone>248-849-889</phone>
      <email>nicole.bolda@stjohn.org</email>
    </contact_backup>
    <investigator>
      <last_name>Bradford A Whitmer, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ritchie G, Burgess L, Mostafa S, Wenstone R. Preventing constipation in critically ill patients. Nurs Times. 2008 Nov 18-24;104(46):42-4.</citation>
    <PMID>19054971</PMID>
  </reference>
  <reference>
    <citation>Patanwala AE, Abarca J, Huckleberry Y, Erstad BL. Pharmacologic management of constipation in the critically ill patient. Pharmacotherapy. 2006 Jul;26(7):896-902.</citation>
    <PMID>16803421</PMID>
  </reference>
  <reference>
    <citation>Chappell D, Rehm M, Conzen P. Opioid-induced constipation in intensive care patients: relief in sight? Crit Care. 2008;12(4):161. doi: 10.1186/cc6930. Epub 2008 Jul 1.</citation>
    <PMID>18598388</PMID>
  </reference>
  <reference>
    <citation>Mostafa SM, Bhandari S, Ritchie G, Gratton N, Wenstone R. Constipation and its implications in the critically ill patient. Br J Anaesth. 2003 Dec;91(6):815-9.</citation>
    <PMID>14633751</PMID>
  </reference>
  <reference>
    <citation>Tittle M, McMillan SC. Pain and pain-related side effects in an ICU and on a surgical unit: nurses' management. Am J Crit Care. 1994 Jan;3(1):25-30.</citation>
    <PMID>7906992</PMID>
  </reference>
  <reference>
    <citation>Viscusi ER, Gan TJ, Leslie JB, Foss JF, Talon MD, Du W, Owens G. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability. Anesth Analg. 2009 Jun;108(6):1811-22. doi: 10.1213/ane.0b013e31819e0d3a. Review.</citation>
    <PMID>19448206</PMID>
  </reference>
  <reference>
    <citation>Arpino PA, Thompson BT. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit. J Clin Pharm Ther. 2009 Apr;34(2):171-5. doi: 10.1111/j.1365-2710.2008.00982.x.</citation>
    <PMID>19250137</PMID>
  </reference>
  <reference>
    <citation>McKenna S, Wallis M, Brannelly A, Cawood J. The nursing management of diarrhoea and constipation before and after the implementation of a bowel management protocol. Aust Crit Care. 2001 Feb;14(1):10-6.</citation>
    <PMID>11899755</PMID>
  </reference>
  <reference>
    <citation>Dorman BP, Hill C, McGrath M, Mansour A, Dobson D, Pearse T, Singleton J, Al-Omoush A, Barry M, Colongon AR, Perez M, Fitzgerald D, Zabala M. Bowel management in the intensive care unit. Intensive Crit Care Nurs. 2004 Dec;20(6):320-9.</citation>
    <PMID>15567673</PMID>
  </reference>
  <reference>
    <citation>Hill S, Anderson J, Baker K, Bonson B, Gager M, Lake E. Management of constipation in the critically ill patient. Nurs Crit Care. 1998 May-Jun;3(3):134-7. Review.</citation>
    <PMID>9883173</PMID>
  </reference>
  <reference>
    <citation>Sanz Rubiales A, del Valle Rivero ML. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008 Sep 4;359(10):1070-1; author reply 1071. doi: 10.1056/NEJMc081373.</citation>
    <PMID>18768955</PMID>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2010</study_first_submitted>
  <study_first_submitted_qc>January 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2010</study_first_posted>
  <last_update_submitted>January 13, 2010</last_update_submitted>
  <last_update_submitted_qc>January 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bradford Whitmer, DO</name_title>
    <organization>Providence Medical Center and Hospital</organization>
  </responsible_party>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Constipation</keyword>
  <keyword>Bowel Management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Methylnaltrexone</mesh_term>
    <mesh_term>Naltrexone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

